SynthesisClinical genitourinary cancer2020

Programmed Death 1 and Programmed Death Ligand 1 Inhibitors in Advanced and Recurrent Urothelial Carcinoma: Meta-analysis of Single-Agent Studies.

Alessandro Tafuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.